%0 Journal Article
%T Efficacy of cefoxitin for the treatment of urinary tract infection
due to extended-spectrum-beta-lactamase-producing Escherichia
coli and Klebsiella pneumoniae
isolates
%A Aur¨¦lien Dinh
%A Benjamin Davido
%A Christian Perronne
%A Fr¨¦d¨¦rique Bouchand
%A Laurene Deconinck
%A Lesly Fellous
%A Martin Rottman
%A Morgan Matt
%A Olivia Senard
%J Archive of "Therapeutic Advances in Infectious Disease".
%D 2019
%R 10.1177/2049936118811053
%X Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by extended-spectrum beta-lactamases and is a good candidate for the treatment of urinary tract infection. However, data are scarce regarding its use in clinical practice
%K Cefoxitin
%K Escherichia coli
%K extended-spectrum beta-lactamase
%K Klebsiella pneumoniae
%K urinary tract infection
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416675/